Rajesh Gandhi
Expertise in
7
conditions

Dr. Rajesh Gandhi

Infectious Disease
Massachusetts General Hospital
55 Fruit St, 
Boston, MA 
32 Years of Experience
Expertise in
7
conditions
Massachusetts General Hospital
55 Fruit St, 
Boston, MA 

Overview

Rajesh Gandhi is an Infectious Disease provider practicing medicine in Boston, Massachusetts. He has been practicing medicine for over 32 years.

Dr. Gandhi is highly rated in 7 conditions, according to our data. His clinical expertise encompasses HIV/AIDS, Sepsis, AIDS Dementia Complex, and Myelitis.

He is actively involved in clinical research, co-authoring 184 peer reviewed articles and participating in 10 clinical trials.

Specialties

Infectious Disease

Licenses

Internal Medicine in MA

Hospital Affiliations

Massachusetts General Hospital

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Commonwealth Care Alliance
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Mass General Brigham Health Plan
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Neighborhood
  • MANAGED MEDICAID PLAN
  • MEDICARE ASSISTANCE PROGRAM
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
Tufts
  • HMO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 8 Less Insurance Carriers -

Locations

Massachusetts General Hospital
55 Fruit St, Boston, MA 02114

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

10 Clinical Trials

Effect of Antiretroviral Treatment Initiated During Acute HIV-1 Infection on Measures of HIV-1 Persistence and on HIV-1-Specific Immune Responses
Effect of Antiretroviral Treatment Initiated During Acute HIV-1 Infection on Measures of HIV-1 Persistence and on HIV-1-Specific Immune Responses
Enrollment Status: Completed
Publish Date: August 29, 2025
Intervention Type: Drug
Study Drug: Elvitegravir+Cobicistat+Emtricitabine+Tenofovir alafenamide or other medically-appropriate FDA-approved antiretroviral therapy
Study Phase: Phase 2
Doravirine for Obese Persons on Integrase Inhibitors and Tenofovir Alafenamide (The Do IT Study)
Doravirine for Obese Persons on Integrase Inhibitors and Tenofovir Alafenamide (The Do IT Study)
Enrollment Status: Completed
Publish Date: July 02, 2025
Intervention Type: Drug
Study Drugs: Doravirine, Tenofovir alafenamide, Emtricitabine, Lamivudine, Integrase strand transfer inhibitors, Tenofovir disproxil fumarate
Study Phase: Phase 4
Identification of Biomarkers to Predict Time to Plasma HIV RNA Rebound and Post-Treatment Viral Control During an Intensively Monitored Antiretroviral Pause (IMAP)
Identification of Biomarkers to Predict Time to Plasma HIV RNA Rebound and Post-Treatment Viral Control During an Intensively Monitored Antiretroviral Pause (IMAP)
Enrollment Status: Completed
Publish Date: December 13, 2024
Intervention Type: Drug
Pitavastatin to REduce Physical Function Impairment and FRailty in HIV (PREPARE)
Pitavastatin to REduce Physical Function Impairment and FRailty in HIV (PREPARE)
Enrollment Status: Completed
Publish Date: October 28, 2024
Intervention Type: Drug
Study Phase: Phase 3
Glecaprevir/Pibrentasvir Fixed-dose Combination Treatment for Acute Hepatitis C Virus Infection (PURGE-C)
Glecaprevir/Pibrentasvir Fixed-dose Combination Treatment for Acute Hepatitis C Virus Infection (PURGE-C)
Enrollment Status: Completed
Publish Date: July 11, 2024
Intervention Type: Drug
Study Drugs: Glecaprevir+Pibrentasvir, Ribavirin
Study Phase: Phase 2
A Single-arm Study to Evaluate the Feasibility and Efficacy of a Minimal Monitoring Strategy to Deliver Pan-genotypic Ribavirin-free HCV Therapy to HCV Infected Populations Who Are HCV Treatment Naïve With Evidence of Active HCV Infection: The MINMON Study
A Single-arm Study to Evaluate the Feasibility and Efficacy of a Minimal Monitoring Strategy to Deliver Pan-genotypic Ribavirin-free HCV Therapy to HCV Infected Populations Who Are HCV Treatment Naïve With Evidence of Active HCV Infection: The MINMON Study
Enrollment Status: Completed
Publish Date: February 04, 2022
Intervention Type: Drug, Other
Study Phase: Phase 4
Safety and Efficacy of Sirolimus for HIV Reservoir Reduction in Individuals on Suppressive Antiretroviral Therapy
Safety and Efficacy of Sirolimus for HIV Reservoir Reduction in Individuals on Suppressive Antiretroviral Therapy
Enrollment Status: Completed
Publish Date: August 03, 2021
Intervention Type: Drug
Study Phase: Phase 1/Phase 2
Safety, Tolerability, and Effects of the Probiotic Visbiome Extra Strength on Gut Microbiome and Immune Activation Markers in HIV-Infected Participants on Suppressive Antiretroviral Therapy: A Phase II Study
Safety, Tolerability, and Effects of the Probiotic Visbiome Extra Strength on Gut Microbiome and Immune Activation Markers in HIV-Infected Participants on Suppressive Antiretroviral Therapy: A Phase II Study
Enrollment Status: Completed
Publish Date: January 06, 2020
Intervention Type: Drug
Study Phase: Phase 2
A Study to Evaluate Dolutegravir Plus Lamivudine Dual Therapy for the Treatment of Naïve HIV-1-infected Participants
A Study to Evaluate Dolutegravir Plus Lamivudine Dual Therapy for the Treatment of Naïve HIV-1-infected Participants
Enrollment Status: Completed
Publish Date: May 09, 2018
Intervention Type: Drug
Study Phase: Phase 2
Sofosbuvir-Containing Regimens Without Interferon For Treatment of Acute HCV in HIV-1 Infected Individuals (SWIFT-C)
Sofosbuvir-Containing Regimens Without Interferon For Treatment of Acute HCV in HIV-1 Infected Individuals (SWIFT-C)
Enrollment Status: Completed
Publish Date: April 27, 2018
Intervention Type: Drug
Study Phase: Phase 1
View 9 Less Clinical Trials

184 Total Publications

Tecovirimat for the Treatment of Mpox.
Tecovirimat for the Treatment of Mpox.
Journal: The New England journal of medicine
Published: February 25, 2026
Similar Doctors
Expertise in
9
conditions
Dr. Kenneth Mayer
Infectious Disease
Expertise in
9
conditions
Dr. Kenneth Mayer
Infectious Disease

Fenway Community Health Center Inc.

1340 Boylston St, 
Boston, MA 
 (2.0 miles away)
617-927-6087
Languages Spoken:
English
See accepted insurances

Kenneth Mayer is an Infectious Disease provider practicing medicine in Boston, Massachusetts. Dr. Mayer is highly rated in 9 conditions, according to our data. His clinical expertise encompasses HIV/AIDS, Syphilis, Gonorrhea, Chlamydia, and Tissue Biopsy.

Expertise in
13
conditions
Dr. Isaac Bogoch
Infectious Disease
Expertise in
13
conditions
Dr. Isaac Bogoch
Infectious Disease

Office

55 Fruit St # 504, 
Boston, MA 
 (0.1 miles away)
617-726-3812
Languages Spoken:
English

Isaac Bogoch is an Infectious Disease provider practicing medicine in Boston, Massachusetts. Dr. Bogoch is highly rated in 13 conditions, according to our data. His clinical expertise encompasses Typhoid Fever, Salmonella Enterocolitis, Distomatosis, and Schistosomiasis.

Expertise in
8
conditions
Dr. Regina Larocque
Infectious Disease
Expertise in
8
conditions
Dr. Regina Larocque
Infectious Disease

Massachusetts General Hospital

55 Fruit St, 
Boston, MA 
 (0.1 miles away)
617-643-5557
Languages Spoken:
English
See accepted insurances

Regina Larocque is an Infectious Disease provider practicing medicine in Boston, Massachusetts. Dr. Larocque is highly rated in 8 conditions, according to our data. Her clinical expertise encompasses Cholera, Yellow Fever, Salmonella Enterocolitis, and Typhoid Fever.

Frequently Asked Questions about Dr. Rajesh Gandhi

How do I make an appointment with Dr. Rajesh Gandhi?

You can book an appointment with Dr. Rajesh Gandhi by calling their office at 617-726-8403. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Rajesh Gandhi a top-rated expert for HIV/AIDS?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Rajesh Gandhi is classified as an Elite expert for HIV/AIDS, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Rajesh Gandhi specialize in?

While Dr. Rajesh Gandhi is a Infectious Disease, they have specific expertise in HIV/AIDS, Sepsis, and AIDS Dementia Complex. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Infectious Disease.

Does Dr. Rajesh Gandhi participate in research or clinical trials?

Yes. Dr. Rajesh Gandhi has published 184 articles and abstracts on conditions like HIV/AIDS. You can view a list of Dr. Rajesh Gandhi's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Rajesh Gandhi accept my insurance?

Dr. Rajesh Gandhi accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 617-726-8403 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Gandhi's expertise for a condition
ConditionClose
View All 14 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile